A phase 2b study of GWP42003 in Schizophrenia
Latest Information Update: 06 Nov 2020
At a glance
- Drugs Cannabidiol (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
Most Recent Events
- 03 Nov 2020 Status changed from planning to recruiting, according to a GW Pharmaceuticals media release.
- 11 May 2020 According to a GW Pharmaceuticals media release,Start of new clinical programs delayed until H2 2020 due to current COVID restrictions
- 12 Nov 2019 New trial record